Structure Therapeutics Inc. American depositary receipts dropped 40% premarket on Monday after the company released new data from a study of GSBR-1290, its.
Structure Therapeutics Inc.’s American depositary receipts jumped more than 90% premarket on Friday after the company announced positive results from an.